Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio F Silva

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Hepatology|July 2, 2011
Criteria for liver transplantation for HCC: what should the limits be?Mauricio F Silva, Morris Sherman
Journal of Gastroenterology and Hepatology|July 3, 2010
Current controversies surrounding liver transplantation for hepatocellular carcinomaMauricio F Silva, Alan J Wigg
Clinics (Sao Paulo, Brazil)|June 20, 2013
Is hepatic venous pressure gradient assessment required before liver resection in patients with cirrhosis and hepatocellular carcinoma?Mauricio F Silva, Simone I Strasser, Flair J Carrilho
Current Opinion in Supportive and Palliative Care|March 18, 2017
Use of corticosteroids for pain control in cancer patients with bone metastases: a comprehensive literature reviewFiona M Y Lim, Adam Bobrowski, Arnav Agarwal, et al.
Kidney International|December 16, 2010
Pseudoporphyria associated with hemodialysisRicardo H M Felix, Mauricio F Silva, Jose B Almeida, et al.
Annals of Hepatology|February 5, 2016
Good outcomes of liver transplantation for hepatitis C at a low volume centreYin Lau Su, Richard J Woodman, Mauricio F Silva, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 2021
Advances in radiotherapy in bone metastases in the context of new target therapies and ablative alternatives: A critical reviewAndré G Gouveia, Dominic C W Chan, Peter J Hoskin, et al.
Tumori|July 1, 2017
Hypofractionated radiotherapy for complicated bone metastases in patients with poor performance status: a phase II international trialMauricio F Silva, Gustavo N Marta, Felipe P C Lisboa, et al.
Annals of Hepatology|October 22, 2014
m-RECIST at 1 month and Child A are survival predictors after percutaneous ethanol injection of hepatocellular carcinomaMauricio F Silva, Flair J Carrilho, Denise C Paranaguá-Vezozzo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Hepatology|July 2, 2011
Criteria for liver transplantation for HCC: what should the limits be?Mauricio F Silva, Morris Sherman
Journal of Gastroenterology and Hepatology|July 3, 2010
Current controversies surrounding liver transplantation for hepatocellular carcinomaMauricio F Silva, Alan J Wigg
Clinics (Sao Paulo, Brazil)|June 20, 2013
Is hepatic venous pressure gradient assessment required before liver resection in patients with cirrhosis and hepatocellular carcinoma?Mauricio F Silva, Simone I Strasser, Flair J Carrilho
Current Opinion in Supportive and Palliative Care|March 18, 2017
Use of corticosteroids for pain control in cancer patients with bone metastases: a comprehensive literature reviewFiona M Y Lim, Adam Bobrowski, Arnav Agarwal, et al.
Kidney International|December 16, 2010
Pseudoporphyria associated with hemodialysisRicardo H M Felix, Mauricio F Silva, Jose B Almeida, et al.
Annals of Hepatology|February 5, 2016
Good outcomes of liver transplantation for hepatitis C at a low volume centreYin Lau Su, Richard J Woodman, Mauricio F Silva, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 2021
Advances in radiotherapy in bone metastases in the context of new target therapies and ablative alternatives: A critical reviewAndré G Gouveia, Dominic C W Chan, Peter J Hoskin, et al.
Tumori|July 1, 2017
Hypofractionated radiotherapy for complicated bone metastases in patients with poor performance status: a phase II international trialMauricio F Silva, Gustavo N Marta, Felipe P C Lisboa, et al.
Annals of Hepatology|October 22, 2014
m-RECIST at 1 month and Child A are survival predictors after percutaneous ethanol injection of hepatocellular carcinomaMauricio F Silva, Flair J Carrilho, Denise C Paranaguá-Vezozzo, et al.
Pageof 1